Thus, it has been suggested that the increases in FGF21 that parallel aging are related to the appearance of an age‐related FGF21‐resistant state, as has been proposed in metabolic diseases (Salminen, Kaarniranta, & Kauppinen, 2017). The gene discussed is FGF21; the disease is Other metabolic disease.